share_log

中科生物(01237.HK)中期收益下跌40.4%至1.79亿元

The medium-term earnings of Zhongke Biology (01237.HK) fell 40.4% to 179 million yuan

Gelonghui Finance ·  Aug 31, 2023 08:06

China Science Biology (01237.HK) announced on August 31 that in the six months to June 30, 2023, the company's income fell 40.4% compared with the same period last year to 179.4 million yuan. After a shortage of building materials caused by a strong global real estate market last year, demand for wood products cooled significantly. During the period, the Group recorded a gross profit margin of 12.1% (first half of 2022: 9.5%). As the group concentrated on higher gross margin products, the group recorded a gross profit of 21.7 million yuan (first half of 2022: 28.5 million yuan).

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment